Position in RDY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$33,361,339
+$3,297,768 QoQ
Shares Held
2,408,761
+12.5% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $619,344,789 across 33 Drug Manufacturers - Specialty & Generic names. RDY ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
300,204 | $178,014,967 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
1,336,313 | $64,343,470 | |
| 3 | ZTS |
Zoetis Inc.
|
440,797 | $52,106,613 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
350,710 | $46,202,535 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,391,612 | $42,416,333 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
617,072 | $34,130,252 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
This page
|
2,408,761 | $33,361,339 | |
| 8 | VTRS |
Viatris Inc
|
2,042,257 | $27,590,892 |
All Filings in RDY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,361,339 | 2,408,761 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $30,063,571 | 2,141,280 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $28,026,363 | 2,004,747 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $31,808,860 | 2,116,358 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $19,409,388 | 1,471,523 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $22,862,988 | 1,447,941 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $25,896,330 | 325,945 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $20,505,090 | 269,131 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $14,387,822 | 196,153 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $14,703,715 | 211,321 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $18,072,286 | 270,260 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,440,347 | 212,967 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $11,476,404 | 201,588 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,440,960 | 124,463 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,524,905 | 105,558 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,306,915 | 95,810 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $6,133,309 | 110,054 | Shares | Defined | 2022-05-12 | |
| 2021-09-30 | $24,492 | 376 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,270,710 | 58,097 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,216,615 | 84,975 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $9,355,315 | 131,229 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $10,659,722 | 153,245 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $12,363,787 | 233,235 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||